PL378877A1 - Zastosowanie rimeksolonu do leczenia zespołu suchego oka - Google Patents
Zastosowanie rimeksolonu do leczenia zespołu suchego okaInfo
- Publication number
- PL378877A1 PL378877A1 PL378877A PL37887703A PL378877A1 PL 378877 A1 PL378877 A1 PL 378877A1 PL 378877 A PL378877 A PL 378877A PL 37887703 A PL37887703 A PL 37887703A PL 378877 A1 PL378877 A1 PL 378877A1
- Authority
- PL
- Poland
- Prior art keywords
- rimexolone
- treatment
- dry eye
- eye
- dry
- Prior art date
Links
- 208000003556 Dry Eye Syndromes Diseases 0.000 title 1
- 206010013774 Dry eye Diseases 0.000 title 1
- QTTRZHGPGKRAFB-OOKHYKNYSA-N rimexolone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CC)(C)[C@@]1(C)C[C@@H]2O QTTRZHGPGKRAFB-OOKHYKNYSA-N 0.000 title 1
- 229960001487 rimexolone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43625502P | 2002-12-24 | 2002-12-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL378877A1 true PL378877A1 (pl) | 2006-05-29 |
Family
ID=32682365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL378877A PL378877A1 (pl) | 2002-12-24 | 2003-12-18 | Zastosowanie rimeksolonu do leczenia zespołu suchego oka |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US20040132704A1 (pl) |
| EP (1) | EP1575597B1 (pl) |
| JP (1) | JP2006513213A (pl) |
| KR (2) | KR20090018222A (pl) |
| CN (1) | CN100388919C (pl) |
| AR (1) | AR042790A1 (pl) |
| AT (1) | ATE419856T1 (pl) |
| AU (1) | AU2003299696B2 (pl) |
| BR (1) | BR0317774A (pl) |
| CA (1) | CA2507375C (pl) |
| CY (1) | CY1108862T1 (pl) |
| DE (1) | DE60325770D1 (pl) |
| DK (1) | DK1575597T3 (pl) |
| ES (1) | ES2316867T3 (pl) |
| MX (1) | MXPA05006985A (pl) |
| PL (1) | PL378877A1 (pl) |
| PT (1) | PT1575597E (pl) |
| RU (1) | RU2330668C2 (pl) |
| SI (1) | SI1575597T1 (pl) |
| TW (1) | TWI335819B (pl) |
| UY (1) | UY28126A1 (pl) |
| WO (1) | WO2004058273A1 (pl) |
| ZA (1) | ZA200503975B (pl) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040033228A1 (en) | 2002-08-16 | 2004-02-19 | Hans-Juergen Krause | Formulation of human antibodies for treating TNF-alpha associated disorders |
| US7779039B2 (en) | 2004-04-02 | 2010-08-17 | Salesforce.Com, Inc. | Custom entities and fields in a multi-tenant database system |
| WO2006031848A2 (en) * | 2004-09-15 | 2006-03-23 | Ivax Corporation | Corticosteroid topical dispersion with low content of surfactant |
| WO2007030796A2 (en) | 2005-09-09 | 2007-03-15 | Salesforce.Com, Inc. | Systems and methods for exporting, publishing, browsing and installing on-demand applications in a multi-tenant database environment |
| SG10202003901UA (en) | 2005-12-13 | 2020-05-28 | Incyte Holdings Corp | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| US8138156B2 (en) * | 2006-10-18 | 2012-03-20 | Bausch & Lomb Incorporated | Ophthalmic compositions containing diglycine |
| KR20150036210A (ko) | 2007-06-13 | 2015-04-07 | 인사이트 코포레이션 | 야누스 키나제 억제제（Ｒ）―３―（４―（７Ｈ―피롤로［２，３－ｄ］피리미딘―4―일）―1Ｈ―피라졸―1―일）―３―사이클로펜틸프로판니트릴의 염 |
| US8629099B2 (en) * | 2008-03-25 | 2014-01-14 | Bausch & Lomb Incorporated | Ophthalmic compositions comprising a dipeptide |
| CL2009001884A1 (es) * | 2008-10-02 | 2010-05-14 | Incyte Holdings Corp | Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco. |
| US20100087550A1 (en) * | 2008-10-06 | 2010-04-08 | Zora Marlowe | Formulations with a Tertiary Amine Oxide |
| SI2432472T1 (sl) * | 2009-05-22 | 2019-11-29 | Incyte Holdings Corp | 3-(4-(7H-pirolo(2,3-d)pirimidin-4-il)-1H-pirazol-1-il)oktan- ali heptan-nitril kot inhibitorji JAK |
| AR076794A1 (es) | 2009-05-22 | 2011-07-06 | Incyte Corp | Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo [2,3-d]pirimidinas y pirrol-3-il-pirrolo [2,3-d ]pirimidinas como inhibidores de la quinasa janus y composiciones farmaceuticas que los contienen |
| MX358504B (es) * | 2009-06-05 | 2018-08-21 | Allergan Inc | Lagrimas artificiales y usos terapeuticos. |
| TW201113285A (en) * | 2009-09-01 | 2011-04-16 | Incyte Corp | Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors |
| EP3354652B1 (en) | 2010-03-10 | 2020-05-06 | Incyte Holdings Corporation | Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
| PE20130216A1 (es) | 2010-05-21 | 2013-02-27 | Incyte Corp | Formulacion topica para un inhibidor de jak |
| PE20140146A1 (es) | 2010-11-19 | 2014-02-06 | Incyte Corp | Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak |
| US9034884B2 (en) | 2010-11-19 | 2015-05-19 | Incyte Corporation | Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors |
| CN103797010B (zh) | 2011-06-20 | 2016-02-24 | 因塞特控股公司 | 作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物 |
| TW201313721A (zh) | 2011-08-18 | 2013-04-01 | Incyte Corp | 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物 |
| UA111854C2 (uk) | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
| US8664180B2 (en) | 2012-02-06 | 2014-03-04 | Bausch & Lomb Incorporated | Ophthalmic compositions containing diglycine |
| US8324171B1 (en) | 2012-02-06 | 2012-12-04 | Bausch & Lomb Incorporated | Ophthalmic compositions containing diglycine |
| US9549966B2 (en) | 2012-02-21 | 2017-01-24 | Massachusetts Eye & Ear Infirmary | Inflammatory eye disorders |
| TW201406761A (zh) | 2012-05-18 | 2014-02-16 | Incyte Corp | 做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物 |
| PH12020551186B1 (en) | 2012-11-15 | 2024-03-20 | Incyte Holdings Corp | Sustained-release dosage forms of ruxolitinib |
| RS62867B1 (sr) | 2013-03-06 | 2022-02-28 | Incyte Holdings Corp | Postupci i intermedijeri za dobijanje inhibitora jak |
| SMT202000315T1 (it) | 2013-08-07 | 2020-07-08 | Incyte Corp | Forme di dosaggio a rilascio prolungato per un inibitore di jak1 |
| RU2559580C1 (ru) * | 2014-03-18 | 2015-08-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный педиатрический медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СПбГПМУ Минздрава России) | Препарат для лечения синдрома "сухого глаза" |
| US9498467B2 (en) | 2014-05-30 | 2016-11-22 | Incyte Corporation | Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1 |
| CN106581035A (zh) * | 2016-12-06 | 2017-04-26 | 郑州郑先医药科技有限公司 | 一种治疗干眼病的西药组合物 |
| CN106420797A (zh) * | 2016-12-06 | 2017-02-22 | 郑州郑先医药科技有限公司 | 一种治疗干眼病的西药组合及其制备方法 |
| WO2019113487A1 (en) | 2017-12-08 | 2019-06-13 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
| SG11202007164UA (en) | 2018-01-30 | 2020-08-28 | Incyte Corp | Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one) |
| SMT202400306T1 (it) | 2018-03-30 | 2024-09-16 | Incyte Corp | Trattamento dell'idrosadenite suppurativa utilizzando inibitori di jak. |
| KR102269835B1 (ko) | 2019-10-08 | 2021-06-29 | 한국전력공사 | 펜형 케이블 식별장치 및 케이블 식별 시스템 |
| US11833155B2 (en) | 2020-06-03 | 2023-12-05 | Incyte Corporation | Combination therapy for treatment of myeloproliferative neoplasms |
| US20240166971A1 (en) * | 2022-10-26 | 2024-05-23 | Bausch + Lomb Ireland Limited | Contact lens treating solution |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63203620A (ja) * | 1985-10-30 | 1988-08-23 | アルコン ラボラトリ−ズ インコ−ポレイテツド | 眼科用の抗炎症性組成物 |
| US4686214A (en) * | 1985-10-30 | 1987-08-11 | Alcon Laboratories, Inc. | Anti-inflammatory compounds for ophthalmic use |
| US5360611A (en) * | 1988-10-03 | 1994-11-01 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation |
| US5461081A (en) * | 1989-09-28 | 1995-10-24 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
| USRE34578E (en) * | 1990-05-07 | 1994-04-05 | Lubkin; Virginia | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
| US5460834A (en) * | 1991-12-13 | 1995-10-24 | Alcon Laboratories, Inc. | Combinations of polymers for use in physiological tear compositions |
| WO1993017664A1 (en) * | 1992-03-02 | 1993-09-16 | Alcon Laboratories, Inc. | Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions |
| JPH07508716A (ja) * | 1992-04-21 | 1995-09-28 | ザ スキーペンズ アイ リサーチ インスティテュート，インコーポレイテッド | シェーグレン症候群における眼のアンドロゲン療法 |
| ATE300936T1 (de) * | 1992-05-06 | 2005-08-15 | Alcon Lab Inc | Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen |
| US5505953A (en) * | 1992-05-06 | 1996-04-09 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
| JPH06153607A (ja) * | 1992-11-30 | 1994-06-03 | Kinsaku Kida | 農耕用作業車と農耕作業部との連結装置 |
| CA2134376C (en) * | 1993-12-20 | 2001-10-23 | Haresh G. Bhagat | Combinations of polymers for use in physiological tear compositions |
| WO1997020578A1 (en) * | 1995-12-04 | 1997-06-12 | University Of Miami | Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance |
| RU2126669C1 (ru) * | 1997-04-25 | 1999-02-27 | Новокузнецкий государственный институт усовершенствования врачей | Способ лечения синдрома сухого глаза |
| TR199902812T2 (xx) * | 1997-06-04 | 2000-06-21 | Akzo Nobel N.V. | Kronik enflamatuar ba��rsak hastal�klar�n�n tedavisi i�in anti-enflamatuar steroidlerin kullan�lmas�. |
| JP2003510263A (ja) * | 1999-09-24 | 2003-03-18 | アルコン，インコーポレイテッド | シプロフロキサシンおよびデキサメタゾンを含有する局所用懸濁処方物 |
-
2003
- 2003-12-15 TW TW092135379A patent/TWI335819B/zh not_active IP Right Cessation
- 2003-12-15 UY UY28126A patent/UY28126A1/es not_active Application Discontinuation
- 2003-12-18 US US10/739,824 patent/US20040132704A1/en not_active Abandoned
- 2003-12-18 JP JP2004563765A patent/JP2006513213A/ja active Pending
- 2003-12-18 KR KR1020097001470A patent/KR20090018222A/ko not_active Withdrawn
- 2003-12-18 SI SI200331489T patent/SI1575597T1/sl unknown
- 2003-12-18 DE DE60325770T patent/DE60325770D1/de not_active Expired - Lifetime
- 2003-12-18 MX MXPA05006985A patent/MXPA05006985A/es active IP Right Grant
- 2003-12-18 EP EP03799978A patent/EP1575597B1/en not_active Expired - Lifetime
- 2003-12-18 ES ES03799978T patent/ES2316867T3/es not_active Expired - Lifetime
- 2003-12-18 PT PT03799978T patent/PT1575597E/pt unknown
- 2003-12-18 BR BR0317774-2A patent/BR0317774A/pt not_active IP Right Cessation
- 2003-12-18 CN CNB200380107558XA patent/CN100388919C/zh not_active Expired - Fee Related
- 2003-12-18 DK DK03799978T patent/DK1575597T3/da active
- 2003-12-18 PL PL378877A patent/PL378877A1/pl not_active Application Discontinuation
- 2003-12-18 KR KR1020057011855A patent/KR100889170B1/ko not_active Expired - Fee Related
- 2003-12-18 WO PCT/US2003/040374 patent/WO2004058273A1/en not_active Ceased
- 2003-12-18 RU RU2005123388/14A patent/RU2330668C2/ru not_active IP Right Cessation
- 2003-12-18 ZA ZA200503975A patent/ZA200503975B/en unknown
- 2003-12-18 CA CA002507375A patent/CA2507375C/en not_active Expired - Fee Related
- 2003-12-18 AT AT03799978T patent/ATE419856T1/de active
- 2003-12-18 AU AU2003299696A patent/AU2003299696B2/en not_active Ceased
- 2003-12-22 AR ARP030104778A patent/AR042790A1/es unknown
-
2005
- 2005-10-14 US US11/250,262 patent/US20060058277A1/en not_active Abandoned
-
2007
- 2007-10-26 US US11/925,178 patent/US20080096852A1/en not_active Abandoned
-
2009
- 2009-03-10 CY CY20091100271T patent/CY1108862T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2507375A1 (en) | 2004-07-15 |
| TWI335819B (en) | 2011-01-11 |
| CA2507375C (en) | 2009-11-24 |
| HK1076248A1 (en) | 2006-01-13 |
| WO2004058273A1 (en) | 2004-07-15 |
| US20040132704A1 (en) | 2004-07-08 |
| UY28126A1 (es) | 2004-06-30 |
| RU2330668C2 (ru) | 2008-08-10 |
| RU2005123388A (ru) | 2006-01-20 |
| PT1575597E (pt) | 2009-02-02 |
| ES2316867T3 (es) | 2009-04-16 |
| ATE419856T1 (de) | 2009-01-15 |
| CY1108862T1 (el) | 2014-07-02 |
| DK1575597T3 (da) | 2009-03-16 |
| BR0317774A (pt) | 2005-11-22 |
| AR042790A1 (es) | 2005-07-06 |
| CN100388919C (zh) | 2008-05-21 |
| AU2003299696B2 (en) | 2009-08-13 |
| DE60325770D1 (de) | 2009-02-26 |
| ZA200503975B (en) | 2006-12-27 |
| TW200418492A (en) | 2004-10-01 |
| AU2003299696A1 (en) | 2004-07-22 |
| KR20050086937A (ko) | 2005-08-30 |
| SI1575597T1 (sl) | 2009-04-30 |
| US20080096852A1 (en) | 2008-04-24 |
| MXPA05006985A (es) | 2005-08-16 |
| EP1575597A1 (en) | 2005-09-21 |
| CN1732008A (zh) | 2006-02-08 |
| KR100889170B1 (ko) | 2009-03-16 |
| KR20090018222A (ko) | 2009-02-19 |
| EP1575597B1 (en) | 2009-01-07 |
| JP2006513213A (ja) | 2006-04-20 |
| US20060058277A1 (en) | 2006-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL378877A1 (pl) | Zastosowanie rimeksolonu do leczenia zespołu suchego oka | |
| AU2003291609A1 (en) | Cb 1/cb 2 receptor ligands and their use in the treatment of pain | |
| IL172316A0 (en) | Novel compounds and their use in therapy | |
| EP1392292A4 (en) | PYRANOINDAZOLES AND THEIR USE IN GLAUCOMA TREATMENT | |
| AU2003286285A1 (en) | Use of fgf-18 in the diagnosis and treatment of memory disorders | |
| AU2002243363A8 (en) | Use of aziridino-compounds in the treatment of immune dysfunctions | |
| IL159879A0 (en) | Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine | |
| GB0108671D0 (en) | Skin treatment | |
| IL157593A0 (en) | Carbamate compounds for use in the treatment of pain | |
| GB0213869D0 (en) | The treatment of pain | |
| AU2003227944A1 (en) | Ddah modulators in the treatment of pain | |
| SG110107A1 (en) | Compound and use in treatment | |
| TWI365187B (en) | 7-azaindoles and the use thereof as therapeutic agents | |
| EP1683765A4 (en) | WATER TREATMENT UNIT AND APPARATUS PROVIDED WITH THIS UNIT | |
| EG24959A (en) | Indoles useful in the treatment of androgenreceptor related diseases. | |
| IL164951A0 (en) | The treatment of pain with lfendropil | |
| GB0106316D0 (en) | Apparatus for use in the treatment of hair | |
| GB2392839A8 (en) | Use of Mycobacterium w in the treatment of tubercolosis | |
| GB2386839B (en) | Apparatus for use in the treatment of choanal atresia | |
| AU2003217432A8 (en) | Angiopoietin-1 in the treatment of disease | |
| GB0310147D0 (en) | A composition for use in the treatment of a skin condition in a subject | |
| GB0312340D0 (en) | Improved game and aricle for use with the game | |
| SI1425008T1 (sl) | Uporaba substituiranih aminometilkromanov za zdravljenje stranskih ucinkov nevroleptikov | |
| AU2003233998A1 (en) | Ddah modulators in the treatment of pain | |
| IL174968A0 (en) | The use of ifenprodil in the treatment of pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |